Wells Fargo’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5K | Hold |
|
|||||
|
2025
Q1 | $1.69K | Hold |
|
|||||
|
2024
Q4 | $3.04K | Sell |
|
|||||
|
2024
Q3 | $12.2K | Buy |
|
|||||
|
2024
Q2 | $9.75K | Sell |
|
|||||
|
2024
Q1 | $16.4K | Sell |
|
|||||
|
2023
Q4 | $8.16K | Sell |
|
|||||
|
2023
Q3 | $8.08K | Buy |
|
|||||
|
2023
Q2 | $76.9K | Buy |
|
|||||
|
2023
Q1 | $81.9K | Buy |
|
|||||
|
2022
Q4 | $32.6K | Sell |
|
|||||
|
2022
Q3 | $90K | Buy |
|
|||||
|
2022
Q2 | $50K | Buy |
|
|||||
|
2022
Q1 | $55K | Sell |
|
|||||
|
2021
Q4 | $74K | Buy |
|
|||||
|
2021
Q3 | $44K | Buy |
|
|||||
|
2021
Q2 | $49K | Sell |
|
|||||
|
2021
Q1 | $116K | Sell |
|
|||||
|
2020
Q4 | $465K | Buy |
|
|||||
|
2020
Q3 | $1.14M | Buy |
|
|||||
|
2020
Q2 | $665K | Buy |
|
|||||
|
2020
Q1 | $73K | Buy |
|
|||||
|
2019
Q4 | $21K | Hold |
|
|||||
|
2019
Q3 | $20K | Sell |
|
|||||
|
2019
Q2 | $20K | Buy |
|
|||||
|
2019
Q1 | $22K | Hold |
|
|||||
|
2018
Q4 | $18K | Sell |
|
|||||
|
2018
Q3 | $56K | Buy |
|
|||||
|
2018
Q2 | $56K | Hold |
|
|||||
|
2018
Q1 | $45K | Buy |
|
|||||
|
2017
Q4 | $44K | Buy |
|
|||||
|
2017
Q3 | $25K | Buy |
|
|||||
|
2017
Q2 | $21K | Hold |
|
|||||
|
2017
Q1 | $21K | Buy |
|
|||||
|
2016
Q4 | $10K | Hold |
|
|||||
|
2016
Q3 | $10K | Buy |
|